{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:47:25Z","timestamp":1790624845757,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T00:00:00Z","timestamp":1428019200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0659-4","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T17:14:58Z","timestamp":1427994898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Fibromyalgia, milnacipran and experimental pain modulation: study protocol for a double blind randomized controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Nicolas","family":"Macian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Dubray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gis\u00e8le","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,3]]},"reference":[{"key":"659_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jbspin.2008.06.002","volume":"76","author":"B Bannwarth","year":"2009","unstructured":"Bannwarth B, Blotman F, Rou\u00e9-Le Lay K, Caub\u00e8re J-P, Andr\u00e9 E, Ta\u00efeb C. Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine. 2009;76:184\u20137.","journal-title":"Joint Bone Spine."},{"key":"659_CR2","first-page":"6","volume":"75","author":"P Mease","year":"2005","unstructured":"Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl. 2005;75:6\u201321.","journal-title":"J Rheumatol Suppl."},{"key":"659_CR3","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3899\/jrheum.101025","volume":"38","author":"JC Branco","year":"2011","unstructured":"Branco JC, Cherin P, Montagne A, Bouroubi A. Multinational coordinator study group. Longterm therapeutic response to milnacipran treatment for fibromyalgia: a European 1-year extension study following a 3-month study. J Rheumatol. 2011;38:1403\u201312.","journal-title":"J Rheumatol."},{"key":"659_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62:600\u201310.","journal-title":"Arthritis Care Res."},{"key":"659_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0304-3959(96)03295-2","volume":"70","author":"E Kosek","year":"1997","unstructured":"Kosek E, Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain. 1997;70:41\u201351.","journal-title":"Pain."},{"key":"659_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00002508-199709000-00003","volume":"13","author":"S Lautenbacher","year":"1997","unstructured":"Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain. 1997;13:189\u201396.","journal-title":"Clin J Pain."},{"key":"659_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0304-3959(94)90002-7","volume":"57","author":"A Sigurdsson","year":"1994","unstructured":"Sigurdsson A, Maixner W. Effects of experimental and clinical noxious counterirritants on pain perception. Pain. 1994;57:265\u201375.","journal-title":"Pain."},{"key":"659_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.pain.2003.09.005","volume":"106","author":"RR Edwards","year":"2003","unstructured":"Edwards RR, Ness TJ, Weigent DA, Fillingim RB. Individual differences in diffuse noxious inhibitory controls (DNIC): association with clinical variables. Pain. 2003;106:427\u201337.","journal-title":"Pain."},{"key":"659_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0304-3959(02)00325-1","volume":"101","author":"R Staud","year":"2003","unstructured":"Staud R, Robinson ME, Vierck Jr CJ, Price DD. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain. 2003;101:167\u201374.","journal-title":"Pain."},{"key":"659_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jpain.2009.10.009","volume":"11","author":"G Van Wijk","year":"2010","unstructured":"Van Wijk G, Veldhuijzen DS. Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. J Pain. 2010;11:408\u201319.","journal-title":"J Pain."},{"key":"659_CR11","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1155\/2014\/507947","volume":"19","author":"G Pickering","year":"2014","unstructured":"Pickering G, Pereira B, Dufour E, Soule S, Dubray C. Impaired modulation of pain in patients with postherpetic neuralgia. Pain Res Manag. 2014;19:e19\u201323.","journal-title":"Pain Res Manag."},{"key":"659_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ejpain.2010.02.004","volume":"14","author":"D Yarnitsky","year":"2010","unstructured":"Yarnitsky D, Arendt-Nielsen L, Bouhassira D, Edwards RR, Fillingim RB, Granot M, et al. Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain. 2010;14:339.","journal-title":"Eur J Pain"},{"key":"659_CR13","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.pain.2012.02.021","volume":"153","author":"D Yarnitsky","year":"2012","unstructured":"Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain. 2012;153:1193\u20138.","journal-title":"Pain."},{"key":"659_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/ard.2007.071522","volume":"67","author":"SF Carville","year":"2008","unstructured":"Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536\u201341.","journal-title":"Ann Rheum Dis."},{"key":"659_CR15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","volume":"136","author":"IJ Russell","year":"2008","unstructured":"Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008;136:432\u201344.","journal-title":"Pain."},{"key":"659_CR16","first-page":"15","volume":"3","author":"MJ Ormseth","year":"2010","unstructured":"Ormseth MJ, Eyler AE, Hammonds CL, Boomershine CS. Milnacipran for the management of fibromyalgia syndrome. J Pain Res. 2010;3:15\u201324.","journal-title":"J Pain Res."},{"key":"659_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/1759720X10372551","volume":"2","author":"RH Palmer","year":"2010","unstructured":"Palmer RH, Periclou A, Banerjee P. Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia. Ther Adv Musculoskelet Dis. 2010;2:201\u201320.","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"659_CR18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/AJP.0b013e31828440ab","volume":"29","author":"LM Arnold","year":"2013","unstructured":"Arnold LM, Palmer RH, Ma Y. A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia. Clin J Pain. 2013;29:1021\u20138.","journal-title":"Clin J Pain."},{"key":"659_CR19","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/papr.12079","volume":"14","author":"G Pickering","year":"2014","unstructured":"Pickering G, Pereira B, Cl\u00e8re F, Sorel M, de Montgazon G, Navez M, et al. Cognitive function in older patients with postherpetic neuralgia. Pain Pract Off J World Inst Pain. 2014;14:E1\u20137.","journal-title":"Pain Pract Off J World Inst Pain."},{"issue":"1","key":"659_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijerph8010015","volume":"8","author":"J Efird","year":"2011","unstructured":"Efird J. Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health. 2011;8(1):15\u201320.","journal-title":"Int J Environ Res Public Health"},{"issue":"1\u20132","key":"659_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pain.2004.12.032","volume":"114","author":"N Julien","year":"2005","unstructured":"Julien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain. 2005;114(1\u20132):295\u2013302.","journal-title":"Pain"},{"key":"659_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.pain.2005.02.017","volume":"115","author":"Y Granovsky","year":"2005","unstructured":"Granovsky Y, Matre D, Sokolik A, Lorenz J, Casey KL. Thermoreceptive innervation of human glabrous and hairy skin: a contact heat evoked potential analysis. Pain. 2005;115:238\u201347.","journal-title":"Pain."},{"issue":"7321","key":"659_CR23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","volume":"323","author":"AJ Vickers","year":"2001","unstructured":"Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323(7321):1123\u20134.","journal-title":"BMJ"},{"key":"659_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nn.3628","volume":"17","author":"F Denk","year":"2014","unstructured":"Denk F, McMahon SB, Tracey I. Pain vulnerability: a neurobiological perspective. Nat Neurosci. 2014;17:192\u2013200.","journal-title":"Nat Neurosci."},{"issue":"4, suppl, 2","key":"659_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jpain.2008.01.090","volume":"9","author":"J Gendreau","year":"2008","unstructured":"Gendreau J, Palmer R, Thacker K. (170) Milnacipran is safe and well tolerated in the treatment of fibromyalgia syndrome. J Pain. 2008;9(4, suppl, 2):18\u20138.","journal-title":"J Pain"},{"key":"659_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pain.2007.10.033","volume":"138","author":"D Yarnitsky","year":"2008","unstructured":"Yarnitsky D, Crispel Y, Eisenberg E, Granovsky Y, Ben-Nun A, Sprecher E, et al. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain. 2008;138:22\u20138.","journal-title":"Pain."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0659-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0659-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0659-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0659-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:43:28Z","timestamp":1630579408000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0659-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["659"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0659-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,3]]},"assertion":[{"value":"4 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"134"}}